| 000 | 00967 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250511213118.0 | ||
| 264 | 0 | _c19911125 | |
| 008 | 199111s 0 0 eng d | ||
| 022 | _a1040-8746 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSymann, M | |
| 245 | 0 | 0 |
_aHematopoietic growth factors as supportive therapy for cancer- and chemotherapy-induced conditions. _h[electronic resource] |
| 260 |
_bCurrent opinion in oncology _cAug 1991 |
||
| 300 |
_a648-55 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAnemia _xchemically induced |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadverse effects |
| 650 | 0 | 4 |
_aHematopoietic Cell Growth Factors _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInfections _xdrug therapy |
| 650 | 0 | 4 |
_aNeoplasms _xblood |
| 650 | 0 | 4 |
_aNeutropenia _xchemically induced |
| 650 | 0 | 4 |
_aThrombocytopenia _xchemically induced |
| 773 | 0 |
_tCurrent opinion in oncology _gvol. 3 _gno. 4 _gp. 648-55 |
|
| 999 |
_c1938417 _d1938417 |
||